ZOETIS INC

ZTS is the ticker symbol for Zoetis Inc., a global animal health company. The stock trades on the New York Stock Exchange and represents ownership in a business focused on medicines, vaccines, diagnostics, and other products for pets and livestock. Zoetis was spun off from Pfizer in 2013 and operates in a specialized segment of the healthcare industry. ZTS is commonly followed by investors interested in animal health trends and companion animal spending.

Recent performance for ZTS depends on current market trading and company-specific news. The page displays the latest price, daily change, and other performance data for ZTS. To assess how the stock has performed over different periods, review the price chart, percentage changes, and historical returns shown on the page. These figures update regularly with market activity.

Evaluating ZTS valuation typically involves comparing its price to earnings, sales, cash flow, and book value, along with growth expectations. Because animal health companies often trade at premiums or discounts relative to broader markets, it helps to compare ZTS against peers in the healthcare and animal health sectors. The page provides relevant valuation ratios and comparison tools to support analysis.

To buy ZTS stock, you generally need a brokerage account that offers access to U.S. exchanges. Once funded, you can place a market or limit order for ZTS shares during regular trading hours. Some brokers also support extended-hours trading and fractional shares. Check your brokerage's fees, order types, and settlement rules before trading. The page may provide links or details about trading ZTS.

Zoetis pays a regular quarterly dividend to shareholders, making ZTS a dividend-paying stock. The exact amount and yield change with the share price and any board decisions, so check the latest dividend data on the page for current figures. Dividend history, payment dates, and payout ratios can help investors understand how Zoetis returns capital.

Key risks for ZTS include competition from other animal health providers, regulatory hurdles for new products, reliance on key drugs and vaccines, and shifts in pet ownership or livestock spending. Currency fluctuations and global economic conditions can also affect results. Additionally, product recalls, patent expirations, and changes in veterinary care trends may impact performance. Reviewing ZTS filings and risk disclosures can provide deeper insight.